Press release
Cancer supportive care industry is expected to reach around USD 34 billion by 2034
Cancer supportive care
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/50185
Market Segmentation Highlights
By Product / Type
• Chemotherapy-Induced Nausea & Vomiting (CINV) management
• Pain management
• Psychological support
• Nutritional support
• Other supportive-care interventions
By Application / Cancer Type
• Breast cancer
• Lung cancer
• Colon cancer
• Prostate cancer
• Other cancers
By End-User / Setting
• Hospitals
• Home-care settings
• Specialty clinics
By Technology / Channel
• Telehealth solutions
• Mobile applications
• Wearable devices
• Distribution channels: pharmacies, online platforms, direct sales
By Region
Regions covered include North America (largest share), Europe, Asia-Pacific (fastest-growing), Latin America and Middle East & Africa.
Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=50185
Growth Drivers, Challenges & Opportunities
Drivers
• Rising global incidence and prevalence of cancer, leading to greater need for supportive care.
• Growing awareness of quality-of-life issues among cancer patients, pushing adoption of supportive interventions.
• Increasing adoption of telehealth, mobile apps and remote monitoring in cancer supportive care.
Challenges
• Access & reimbursement barriers in certain regions limiting uptake of supportive-care products and services.
• Variability in standards and practices for supportive care across geographies.
• High costs and fragmented service provision in home-care and remote settings.
Opportunities
• Expansion of home-care and telehealth models for supportive care, especially in emerging markets.
• Growth in technology-driven solutions (wearables, apps) to monitor and support patients.
• Untapped potential in underserved regions (Asia-Pacific, Latin America) and in less common cancer types.
Strategic Implications
• Providers, biotech firms and med-tech companies should invest in integrated supportive-care offerings combining therapy, monitoring and remote support.
• Healthcare systems should incorporate structured supportive-care protocols (nutritional, psychological, pain management) into cancer treatment workflows.
• Investors should focus on markets with high growth potential (especially Asia-Pacific) and technology-enabled care models.
• Strategic planners must monitor shifts in telehealth capabilities, reimbursement for supportive care services, and patient-centric models focusing on quality of life.
This report is also available in the following languages : Japanese (がん支持療法市場), Korean (암 지원 치료 시장), Chinese (癌症支持治疗市场), French (Marché des soins de soutien en cancérologie), German (Markt für unterstützende Krebsbehandlung), and Italian (Mercato delle cure di supporto al cancro), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/50185/cancer-supportive-care-market#request-a-sample
Our More Reports:
Personalized Medicines In Oncology Market
https://exactitudeconsultancy.com/reports/75561/personalized-medicines-in-oncology-market
Fecal Occult Testing Market
https://exactitudeconsultancy.com/reports/75739/fecal-occult-testing-market
Patient-Derived Xenograft Model Market
https://exactitudeconsultancy.com/reports/75748/patient-derived-xenograft-model-market
Kinase Inhibitors Market
https://exactitudeconsultancy.com/reports/75814/kinase-inhibitors-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer supportive care industry is expected to reach around USD 34 billion by 2034 here
News-ID: 4268814 • Views: …
More Releases from Exactitude Consultancy
Partial Seizure Market to Reach USD 11.24 Billion by 2034 Driven by Rising Epile …
Pune, India - December 2025 - The global Partial Seizure Market, valued at USD 6.82 billion in 2024, is projected to reach USD 11.24 billion by 2034, growing at a 5.2% CAGR (2025-2034), according to Exactitude Consultancy. Increasing global epilepsy burden, development of new anti-seizure medications (ASMs), and expanded access to neurological diagnostics are fueling strong market growth.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/72069
Market Summary
The Partial Seizure Market…
Partial Epilepsy Market to Reach USD 9.36 Billion by 2034
Pune, India - December 2025 - The global Partial Epilepsy Market, valued at USD 5.84 billion in 2024, is projected to reach USD 9.36 billion by 2034, growing at a 4.8% CAGR (2025-2034), according to Exactitude Consultancy. Rising prevalence of focal (partial) seizures, development of improved anti-epileptic drugs (AEDs), and advancements in neuroimaging and neuromodulation therapies are key growth drivers.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/72067
Market Summary
The Partial…
Nucleic Acid and Gene Therapies in Neuromuscular Disorders Market to Reach USD 1 …
Pune, India - December 2025 - The global Nucleic Acid and Gene Therapies in Neuromuscular Disorders Market, valued at USD 6.84 billion in 2024, is projected to reach USD 19.42 billion by 2034, growing at a robust 11.0% CAGR (2025-2034), according to Exactitude Consultancy. Rapid advancements in AAV-based gene therapies, antisense oligonucleotides (ASOs), RNA-targeting technologies, and improved diagnostic pathways are driving strong market momentum.
Download Full PDF Sample Copy of Market…
Prediabetes Market to Reach USD 29.84 Billion by 2034 Driven by Rising Global Di …
Pune, India - December 2025 - The global Prediabetes Market, valued at USD 14.62 billion in 2024, is projected to reach USD 29.84 billion by 2034, growing at a 7.2% CAGR (2025-2034), according to Exactitude Consultancy. The rising prevalence of insulin resistance, sedentary lifestyles, obesity, and increased screening initiatives are fueling substantial market growth.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/72063
Market Summary
The Prediabetes Market is expanding rapidly as healthcare…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
